InvestorsHub Logo
Followers 3
Posts 139
Boards Moderated 0
Alias Born 03/29/2012

Re: Aprilov post# 26233

Tuesday, 10/18/2016 4:46:16 PM

Tuesday, October 18, 2016 4:46:16 PM

Post# of 30361
A little over a year ago the news of Rayva clinical trials and a possible orphan drug status sent the price per share upwards of $2.75. Do not discount the impact that Rayva news could have on the price per share.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News